Valuation: Hofseth BioCare ASA

Market Cap 68Cr 7.3Cr 6.54Cr 6.03Cr 5.46Cr 10Cr 695.04Cr 10Cr 72Cr 29Cr 363.75Cr 27Cr 27Cr 1.15TCr P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 97Cr 10Cr 9.37Cr 8.64Cr 7.82Cr 15Cr 996.04Cr 15Cr 103.12Cr 41Cr 521.28Cr 39Cr 38Cr 1.65TCr EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
74.84%
Yield 2024 *
-
Yield 2025 -
1 day-1.15%
1 week-4.43%
Current month-1.89%
1 month-2.63%
3 months+3.60%
6 months-2.63%
Current year-1.89%
1 week 1.26
Extreme 1.265
1.33
1 month 1.25
Extreme 1.25
1.48
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.06
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.7
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 01/08/2022
Director of Finance/CFO - 01/09/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/05/2015
Director/Board Member - -
Director/Board Member - 03/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/07/23 Buy 74,000 0.0187%
28/02/23 Buy

Chief Technology Officer

2,00,000 0.0506%
17/02/23 Buy

Director

1,00,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%-4.43%-35.25%-53.75% 7.39Cr
0.00%-1.85%+5.53%-15.03% 26TCr
+1.07%-4.08%+8.09%-3.81% 7.9TCr
+1.80%+3.21%-16.41%+16.69% 4.53TCr
-1.33%-4.56%+25.91%+8.79% 3.72TCr
-2.13%-8.75%-8.56%-12.94% 3.29TCr
-1.62%-0.20%+19.85%+87.19% 3.09TCr
+3.20%+3.17%-10.17%-7.50% 2.88TCr
+0.17%-4.74%-1.97%-23.98% 2.83TCr
+2.65%+5.94%+8.35%+9.56% 2.72TCr
Average +0.26%-1.96%-0.46%+0.52% 5.67TCr
Weighted average by Cap. +0.29%-1.65%+4.39%-2.55%

Financials

2024 2025
Net sales 27Cr 2.87Cr 2.57Cr 2.37Cr 2.14Cr 4.01Cr 272.9Cr 4.07Cr 28Cr 11Cr 142.82Cr 11Cr 11Cr 452.35Cr 26Cr 2.77Cr 2.48Cr 2.29Cr 2.07Cr 3.87Cr 263.45Cr 3.93Cr 27Cr 11Cr 137.88Cr 10Cr 10Cr 436.69Cr
Net income -13Cr -1.35Cr -1.21Cr -1.12Cr -1.01Cr -1.89Cr -128.77Cr -1.92Cr -13Cr -5.32Cr -67Cr -5.07Cr -4.97Cr -213.45Cr -13Cr -1.46Cr -1.3Cr -1.2Cr -1.09Cr -2.04Cr -138.62Cr -2.07Cr -14Cr -5.73Cr -73Cr -5.46Cr -5.35Cr -229.77Cr
Net Debt 15Cr 1.57Cr 1.4Cr 1.3Cr 1.17Cr 2.19Cr 149.33Cr 2.23Cr 15Cr 6.17Cr 78Cr 5.89Cr 5.76Cr 247.53Cr 29Cr 3.16Cr 2.83Cr 2.61Cr 2.36Cr 4.42Cr 301Cr 4.49Cr 31Cr 12Cr 157.53Cr 12Cr 12Cr 498.94Cr
Projected Income Statement - Annual - Hofseth BioCare ASA
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
29/26/29 NOK 1.295 -1.15% 10,822
28/26/28 NOK 1.310 0.00% 0
27/26/27 NOK 1.310 -0.38% 44,422
26/26/26 NOK 1.315 -1.50% 1,17,785
23/26/23 NOK 1.335 -1.48% 62,248